STEM CELL TRANSPLANTATION

Stem cell transplant (SCT) is rare in newborns or infants, there has been an associated nursing report encouraging survival rate; yet as there are studies pointing TSS in infants as a questionable treatment. Lung disease remains one of the leading causes of morbidity and mortality in newborns. Cellular medical aid and regenerative drugs have the potential to revolutionize the management of dangerous and debilitating respiratory organ diseases that currently lack effective treatments.

 

  • Morbidity and Mortality in Newborns
  • Lung disease
  • Cellular medical aid

Related Conference of STEM CELL TRANSPLANTATION

June 12-13, 2026

34th International Conference on Nursing Education and Research

Amsterdam, Netherlands
July 27-28, 2026

27th World Congress on Nursing Care and Healthcare

Amsterdam, Netherlands
August 03-04, 2026

5th World Congress on Nursing Education & Management

Barcelona, Spain
August 03-04, 2026

World Nursing Congress

Toronto, Canada
August 24-25, 2026

33rd Global Nursing and Healthcare Congress

London, UK
October 05-06, 2026

45th World Nursing and Healthcare Conference

Rome, Italy
October 19-20, 2026

58th Euro Nursing & Medicare Summit

Paris, France
November 23-24, 2026

63rd World Nursing Conference

Barcelona, Spain

STEM CELL TRANSPLANTATION Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in